IDEAYA Biosciences Q3 EPS $(1.22) Misses $(1.18) Estimate, Sales $10.242M Beat $6.857M Estimate
Benzinga Newsdesk 10 hours ago
NewsEarningsEarnings BeatsEarnings Misses
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.18) by 4.27 percent. This is a 191.73 percent decrease over earnings of $1.33 per share
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.18) by 4.27 percent. This is a 191.73 percent decrease over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $10.242 million which beat the analyst consensus estimate of $6.857 million by 49.36 percent. This is a 95.07 percent decrease over sales of $207.834 million the same period last year.